ZFN-mediated in vivo gene editing in hepatocytes leads to supraphysiologic α-Gal A activity and effective substrate reduction in Fabry mice

Fabry disease, a lysosomal storage disorder resulting from the deficient activity of α-galactosidase A (α-Gal A), is characterized by cardiac, renal, and/or cerebrovascular disease due to progressive accumulation of the enzyme’s substrates, globotriaosylceramide (Gb3) and globotriaosylsphingosine (L...

Descripción completa

Detalles Bibliográficos
Autores principales: Pagant, Silvere, Huston, Marshall W., Moreira, Luciana, Gan, Lin, St Martin, Susan, Sproul, Scott, Holmes, Michael C., Meyer, Kathleen, Wechsler, Thomas, Desnick, Robert J., Yasuda, Makiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8572137/
https://www.ncbi.nlm.nih.gov/pubmed/33775910
http://dx.doi.org/10.1016/j.ymthe.2021.03.018

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8572137/
https://www.ncbi.nlm.nih.gov/pubmed/33775910
http://dx.doi.org/10.1016/j.ymthe.2021.03.018

Ejemplares similares